Logo image of AMRX

AMNEAL PHARMACEUTICALS INC (AMRX) Stock Price, Quote, News and Overview

NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD

8.13  +0.22 (+2.72%)

After market: 8.2 +0.07 (+0.86%)

AMRX Quote, Performance and Key Statistics

AMNEAL PHARMACEUTICALS INC

NASDAQ:AMRX (6/24/2025, 8:15:27 PM)

After market: 8.2 +0.07 (+0.86%)

8.13

+0.22 (+2.72%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High9.48
52 Week Low6.32
Market Cap2.55B
Shares313.42M
Float154.66M
Yearly DividendN/A
Dividend YieldN/A
PE12.51
Fwd PE9.76
Earnings (Next)08-08 2025-08-08/bmo
IPO11-18 2009-11-18


AMRX short term performance overview.The bars show the price performance of AMRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

AMRX long term performance overview.The bars show the price performance of AMRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of AMRX is 8.13 USD. In the past month the price increased by 13.55%. In the past year, price increased by 28.03%.

AMNEAL PHARMACEUTICALS INC / AMRX Daily stock chart

AMRX Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 56.55 737.42B
JNJ JOHNSON & JOHNSON 15.14 366.18B
NVO NOVO-NORDISK A/S-SPONS ADR 19.59 314.28B
NVS NOVARTIS AG-SPONSORED ADR 14.3 234.70B
AZN ASTRAZENECA PLC-SPONS ADR 16.03 218.70B
MRK MERCK & CO. INC. 10.31 201.69B
PFE PFIZER INC 7.57 138.21B
SNY SANOFI-ADR 10.83 117.84B
BMY BRISTOL-MYERS SQUIBB CO 6.41 95.71B
GSK GSK PLC-SPON ADR 8.77 78.39B
ZTS ZOETIS INC 26.21 70.24B
HLN HALEON PLC-ADR 21.41 47.20B

About AMRX

Company Profile

AMRX logo image Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. The company is headquartered in Bridgewater, New Jersey and currently employs 8,100 full-time employees. The company went IPO on 2009-11-18. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Company Info

AMNEAL PHARMACEUTICALS INC

400 Crossing Boulevard, 3rd Floor

Bridgewater NEW JERSEY 08807 US

CEO: Chirag Patel

Employees: 8300

AMRX Company Website

AMRX Investor Relations

Phone: 19089473120

AMNEAL PHARMACEUTICALS INC / AMRX FAQ

What is the stock price of AMNEAL PHARMACEUTICALS INC today?

The current stock price of AMRX is 8.13 USD. The price increased by 2.72% in the last trading session.


What is the ticker symbol for AMNEAL PHARMACEUTICALS INC stock?

The exchange symbol of AMNEAL PHARMACEUTICALS INC is AMRX and it is listed on the Nasdaq exchange.


On which exchange is AMRX stock listed?

AMRX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AMNEAL PHARMACEUTICALS INC stock?

9 analysts have analysed AMRX and the average price target is 11.9 USD. This implies a price increase of 46.37% is expected in the next year compared to the current price of 8.13. Check the AMNEAL PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AMNEAL PHARMACEUTICALS INC worth?

AMNEAL PHARMACEUTICALS INC (AMRX) has a market capitalization of 2.55B USD. This makes AMRX a Mid Cap stock.


How many employees does AMNEAL PHARMACEUTICALS INC have?

AMNEAL PHARMACEUTICALS INC (AMRX) currently has 8300 employees.


What are the support and resistance levels for AMNEAL PHARMACEUTICALS INC (AMRX) stock?

AMNEAL PHARMACEUTICALS INC (AMRX) has a support level at 7.38 and a resistance level at 8.69. Check the full technical report for a detailed analysis of AMRX support and resistance levels.


Is AMNEAL PHARMACEUTICALS INC (AMRX) expected to grow?

The Revenue of AMNEAL PHARMACEUTICALS INC (AMRX) is expected to grow by 8.6% in the next year. Check the estimates tab for more information on the AMRX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AMNEAL PHARMACEUTICALS INC (AMRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AMNEAL PHARMACEUTICALS INC (AMRX) stock pay dividends?

AMRX does not pay a dividend.


When does AMNEAL PHARMACEUTICALS INC (AMRX) report earnings?

AMNEAL PHARMACEUTICALS INC (AMRX) will report earnings on 2025-08-08, before the market open.


What is the Price/Earnings (PE) ratio of AMNEAL PHARMACEUTICALS INC (AMRX)?

The PE ratio for AMNEAL PHARMACEUTICALS INC (AMRX) is 12.51. This is based on the reported non-GAAP earnings per share of 0.65 and the current share price of 8.13 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMRX.


What is the Short Interest ratio of AMNEAL PHARMACEUTICALS INC (AMRX) stock?

The outstanding short interest for AMNEAL PHARMACEUTICALS INC (AMRX) is 2.72% of its float. Check the ownership tab for more information on the AMRX short interest.


AMRX Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to AMRX. When comparing the yearly performance of all stocks, AMRX is one of the better performing stocks in the market, outperforming 75.58% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AMRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AMRX. There are concerns on the financial health of AMRX while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMRX Financial Highlights

Over the last trailing twelve months AMRX reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS decreased by -1.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.39%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%5.5%
EPS 1Y (TTM)-1.52%
Revenue 1Y (TTM)16.73%

AMRX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to AMRX. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 24.28% and a revenue growth 8.6% for AMRX


Ownership
Inst Owners40.32%
Ins Owners46.63%
Short Float %2.72%
Short Ratio2.19
Analysts
Analysts82.22
Price Target11.9 (46.37%)
EPS Next Y24.28%
Revenue Next Year8.6%